COO David Allan Sells $395K of Virtuix Stock Under 10b5-1 Plan
VTIX is trading near its 52-week low of $1.45 (10% above the low).
Summary
Virtuix COO David Allan sold $395K worth of shares at $1.79 under a 10b5-1 plan, reducing his holdings by 44%. The sale adds to a pattern of insider selling despite recent positive company announcements.
Key Events · Ownership and Investor Activity · VTIX
-
COO Sells $395K of Stock
On July 28, 2026, David Allan sold 220,821 shares at $1.79, generating total proceeds of $395,270. The transaction was executed under a Rule 10b5-1 trading plan adopted on March 31, 2026.
-
Stake Reduced by 44%
Following the sale, Allan's direct holdings fell to 279,179 shares from 500,000, marking a 44% reduction.
-
Part of Broader Insider Selling Pattern
This sale extends a pattern of insider selling, coming after CEO Jan Goetgeluk liquidated all his Class A shares earlier in 2026 and other insiders also sold, even as the company announced positive developments such as a Marine Corps contract and the Omni One launch.
-
10b5-1 Plan Mitigates but Does Not Eliminate Concern
Although the sale was pre-planned, the COO's decision to adopt a plan that would offload nearly half his stake suggests limited near-term confidence in share price appreciation.
Analysis · VTIX · Technology
COO David Allan sold 220,821 shares at $1.79, pocketing roughly $395,000. The sale was executed under a pre-existing 10b5-1 trading plan adopted in March 2026, which reduces the signaling weight but does not eliminate it — the COO is still reducing his stake by nearly half. This continues a pattern of insider selling at Virtuix, with the CEO having liquidated all his Class A shares earlier this year. While the company has announced positive operational developments (Marine Corps contract, Omni One launch), insiders are consistently cashing out, which raises questions about their conviction in the stock at current levels.
At the time of this filing, VTIX was trading at $1.60 on NASDAQ in the Technology sector, with a market capitalization of approximately $53M. The 52-week trading range was $1.45 to $92.74. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.